These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique. Goodwin FK; Post RM; Dunner DL; Gordon EK Am J Psychiatry; 1973 Jan; 130(1):73-9. PubMed ID: 4345466 [No Abstract] [Full Text] [Related]
5. Cerebrospinal fluid levels of MHPG in affective disorders. Wilk S; Shopsin B; Gershon S; Suhl M Nature; 1972 Feb; 235(5339):440-1. PubMed ID: 4553689 [No Abstract] [Full Text] [Related]
6. Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex. Gottfries CG; Gottfries I; Johansson B; Olsson R; Persson T; Roos BE; Sjöström R Neuropharmacology; 1971 Nov; 10(6):665-72. PubMed ID: 5128025 [No Abstract] [Full Text] [Related]
7. Estimation of brain amine metabolism in affective illness: cerebrospinal fluid studies utilizing probenecid. Post RM; Goodwin FK Psychother Psychosom; 1974; 23(1-6):142-58. PubMed ID: 4278087 [No Abstract] [Full Text] [Related]
8. CSF acid monoamine metabolities as a possible reflection of central MAO activity in chronic schizophrenia. Bowers MB Biol Psychiatry; 1976 Apr; 11(2):245-9. PubMed ID: 971448 [No Abstract] [Full Text] [Related]
9. Homovanillic and 5-hydroxyindoleacetic acid in cerebrospinal fluid of depressed patients. Papeschi R; McClure DJ Arch Gen Psychiatry; 1971 Oct; 25(4):354-8. PubMed ID: 5116990 [No Abstract] [Full Text] [Related]
11. Acid metabolites from monoamines in cerebrospinal fluid of chronic schizophrenics. Persson T; Roos BE Br J Psychiatry; 1969 Jan; 115(518):95-8. PubMed ID: 5781964 [No Abstract] [Full Text] [Related]
12. Deficient transport mechanism for the removal of acid monoamine metabolites from cerebrospinal fluid. Bowers MB Brain Res; 1969 Oct; 15(2):522-4. PubMed ID: 5344382 [No Abstract] [Full Text] [Related]
13. Effects of -methyltyrosine on the cerebrospinal fluid content of HVA and 5-HIAA in man. Sjöström R Psychopharmacologia; 1971; 22(2):214-6. PubMed ID: 4256511 [No Abstract] [Full Text] [Related]
14. 5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis. Sjöström R; Roos BE Eur J Clin Pharmacol; 1972 Jun; 4(3):170-6. PubMed ID: 4655292 [No Abstract] [Full Text] [Related]
15. Cerebrospinal fluid 5-hydroxyindoleactiic acid and homovanillic acid in psychiatric patients. Bowers MB; Heninger GR; Gerbode F Int J Neuropharmacol; 1969 May; 8(3):255-62. PubMed ID: 5796265 [No Abstract] [Full Text] [Related]
16. Lumbar CSF 5-hydroxyindoleacetic acid and homovanillic acid in affective syndromes. Bowers MB J Nerv Ment Dis; 1974 May; 158(5):325-30. PubMed ID: 4823933 [No Abstract] [Full Text] [Related]
17. Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders. Chase TN; Schnur JA; Gordon EK Neuropharmacology; 1970 May; 9(3):265-8. PubMed ID: 5424003 [No Abstract] [Full Text] [Related]
18. Cerebrospinal fluid 5-hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) following probenecid in unipolar depressives treated with amitriptyline. Bowers MB Psychopharmacologia; 1972; 23(1):26-33. PubMed ID: 5018977 [No Abstract] [Full Text] [Related]
19. 5-Hydroxyindole acetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis and the effect of probenecid treatment. Sjöström R Eur J Clin Pharmacol; 1973 Aug; 6(2):75-80. PubMed ID: 4588853 [No Abstract] [Full Text] [Related]
20. Effect of peripheral decarboxylase inhibition on HVA and 5HIAA in cerebrospinal fluid of depressed patients. Gaillard JM; Constantinidis J; Tissot R Neuropsychobiology; 1975; 1(1):26-31. PubMed ID: 1223666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]